ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups

October 9, 1998

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002

“Acceptable” Images Found In Chest Scans Using Half Dose

August 30, 2002